Flow cytometric enumeration of Class I HLA-restricted, peptide-specific CD8+ T lymphocytes using tetramer technology and single-platform absolute T-cell counting

Journal of Biological Regulators and Homeostatic Agents

Volumn 17, Issue 3, 2003, Pages 268-278

  Kraan, Jan ^a   Arroz, M ^b   Keeney, M ^c   Freire, M ^b   Weir, K ^c   Heijnen, I ^d   Gratama, J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HOSPITAL EGAS MONIZ   (Portugal)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA ANTIGEN CLASS 1; PEPTIDE; TETRAMER;

ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CALCULATION; CHEMICAL PROCEDURES; FLOW CYTOMETRY; HISTOGRAM; INFORMATION PROCESSING; INSTRUMENT; LYMPHOCYTE COUNT; MATHEMATICAL COMPUTING; T LYMPHOCYTE;

EID: 0141961622     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Altman J, Moss PAH, Goulder P, et al. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals. Science 1996; 274: 94-6.
2. Mandy FF, Bergeron M, Recktenwald D, Izaguirre C. A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol. J Immunol Meth 1992; 156: 151-62.
3. Nicholson JKA, Hubbard M, Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry 1996; 26: 16-21.
4. Centers for Disease Control and Prevention (CDC): Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. MMWR 2003; 52 (RR-2): 1-13.
5. Storek J, Golley T, Witherspoon RP, Sullivan KM, Storb R. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997; 54: 131-8.
6. + T lymphocytes in allogeneic stem cell transplantation. Clin Immunol 2003; 106: 29-35.
7. Kraan J, Gratama JW, Keeney M, D'Hautcourt JL. Setting up and calibration of a flow cytometer for multicolor immunophenotyping. J Biol Reg Homeost Agents 2003; 3: 223-33.
8. Brando B, Barnett D, Janossy G, et al for the European Working Group on Clinical Cell Analysis (EWGCCA): Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. Cytometry 2000; 42: 327-46.
9. Whelan JA, Dunbar PR, Price DA, et al. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J Immunol 1999; 163: 4342-8.
10. Keilholz U, Weber J, Finke JH, et al. Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. J Immunother 2002; 25: 97-138.
11. Yee C. Adoptive immunotherapy-immune monitoring and MHC multimers. Clin Immunol 2003; 106: 5-9.
12. Hoffmann TK, Donnenberg AD, Finkelstein SD, et al. Frequencies of tetramer T cells specific for the wild-type sequence p53 (264-272) peptide in the circulation of patients with head and neck cancer. Cancer Res 2002; 62: 3521-9.
13. + T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192: 63-76.
14. + T-cell expansions: evidence for impaired CTL effector function. Eur J Immunol 2001; 31: 677-86.
15. + T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation 2000; 69: 2243-50.
16. + cytotoxic T-lymphocytes in liver transplant recipients. Transplantation 2000; 69: 2251-9.
17. + T lymphocytes in the circulation of pediatric transplant recipients. Transplantation 2002; 74: 501-10.
18. + T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 2001; 98: 1358-64.
19. + T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood 2003; 101: 4290-7.
20. Mutis T, Gillespie G, Schrama E, Falkenburg JHF, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999; 5: 839-42.
21. Marijt WA, Heemskerk MH, Kloosterboer FM, et al. Hematopoiesis-restricted minor histocompatibility antigens HA-1 or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742-7.
22. Hebart H, Daginik S, Stevanovic S, et al. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte response by interferon-γ-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell trans-plantation. Blood 2002; 99: 3830-7.